Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
about
HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanismsThe role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implicationsEffects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalitiesDietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.Whole-body proteolysis rate is elevated in HIV-associated insulin resistance.Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.Increased FDG uptake in association with reduced extremity fat in HIV patients.Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women.Adipose tissue and immune function: a review of evidence relevant to HIV infection.Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects.Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy.Adipose Tissue in HIV Infection.Bone mineral density in people living with HIV: a narrative review of the literature.
P2860
Q21245028-4F2E1E97-B3CC-4D4D-B28C-753959FACF8AQ24598812-A117EF31-CB28-4B94-9A8E-A5D404D9FFE1Q33918414-C0EA27B4-1A28-4AF8-8B08-A7D6E2BCCF26Q35035055-1083D7E5-3989-45CD-B24A-3A31907317DFQ35369261-231FEF89-1B40-45EF-AE54-AD613A55C6CAQ35370152-06E06969-AB89-4B05-84A5-FC806C25C313Q35575238-3C90656E-0592-439D-B697-5021850F4EB4Q35578707-1ABFB635-CD37-494F-B09F-67A10186DE66Q36007239-3F21D11A-7096-456A-B41F-69D7171F655CQ36897050-E4EEE2E0-C82B-4940-8438-B15553D74585Q37161855-CF83EE1D-3E5C-4E9A-ADAD-34C739183999Q37187518-1ACF2827-8E2B-4E28-9A12-305627BAC022Q37214557-3D482E26-D5A9-4ACA-8CB0-CD7148C54696Q37960180-A7C43000-270F-480C-B82A-7F9BD6D1E16CQ40038736-07A9BE4F-CE09-4CCD-9E1D-00DEC6378EDCQ40107245-8D79A17C-C47F-4FB6-9DE1-0E109E96553D
P2860
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@ast
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@en
type
label
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@ast
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@en
prefLabel
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@ast
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@en
P2093
P2860
P1476
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy
@en
P2093
A Fischman
M Torriani
S Grinspoon
P2860
P304
P356
10.1152/AJPENDO.00273.2005
P577
2005-08-30T00:00:00Z